Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17750)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol 2020; 26(2): 109-133 [PMID: 31969775 DOI: 10.3748/wjg.v26.i2.109] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i2/109.htm |
| Number | Citing Articles |
| 1 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 2 |
Emily Chan, Matt Kelly, Julia A. Schnabel. Comparison of Classical Machine Learning & Deep Learning to Characterise Fibrosis & Inflammation Using Quantitative MRI. 2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI) 2021; : 729 doi: 10.1109/ISBI48211.2021.9433962
|
| 3 |
Jongsin Park, Heon-Ju Kwon, Won Sohn, Ju-Yeon Cho, Soo Jin Park, Yoosoo Chang, Seungho Ryu, Byung Ik Kim, Yong Kyun Cho, Chen-Hua Liu. Risk of liver fibrosis in patients with prediabetes and diabetes mellitus. PLOS ONE 2022; 17(6): e0269070 doi: 10.1371/journal.pone.0269070
|
| 4 |
Alexandru Popa, Ioan Sporea, Felix Bende, Alina Popescu, Renata Fofiu, Andreea Borlea, Victor Bâldea, Ariana Pascu, Camelia Gianina Foncea, Radu Cotrău, Roxana Șirli. The Non-Invasive Ultrasound-Based Assessment of Liver Viscosity in a Healthy Cohort. Diagnostics 2022; 12(6): 1451 doi: 10.3390/diagnostics12061451
|
| 5 |
Xiaolei Fang, Jiayu Song, Kaixuan Zhou, Xue Zi, Bin Sun, Huiwei Bao, Lijing Li. Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease. Molecules 2023; 28(15): 5645 doi: 10.3390/molecules28155645
|
| 6 |
Arshi Khanam, Paul G. Saleeb, Shyam Kottilil. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?. Cells 2021; 10(5): 1097 doi: 10.3390/cells10051097
|
| 7 |
Nahla Mohammed Abd El-Hameed, S.A. Abd El-Aleem, Mahmoud A. Khattab, Azza Hussein Ali, Hanaa Hassanein Mohammed. Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH). Life Sciences 2021; 285: 119983 doi: 10.1016/j.lfs.2021.119983
|
| 8 |
Anshika Jangra, Ashish Kothari, Phulen Sarma, Bikash Medhi, Balram Ji Omar, Karanvir Kaushal. Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis. Cells 2022; 11(9): 1500 doi: 10.3390/cells11091500
|
| 9 |
Sumati Rohilla, Savneet Kaur, Rekha Puria. . Advances in Clinical Chemistry 2022; 110: 1 doi: 10.1016/bs.acc.2022.06.001
|
| 10 |
Vishnupriya S, Kowsalya S. Phytochemical Profiling of Various Extracts of <i>Glycine max</i> (L.) Seeds and <i>In-silico</i> Approach for Hepato-Protective Activity. Journal of Natural Remedies 2022; : 607 doi: 10.18311/jnr/2022/29021
|
| 11 |
Yunqi Yao, Zhemin Xia, Fuyi Cheng, Qingyuan Jang, Jiao He, Cheng Pan, Lin Zhang, Yixin Ye, Yuan Wang, Shuang Chen, Dongsheng Su, Xiaolan Su, Lin Cheng, Gang Shi, Lei Dai, Hongxin Deng. Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02358-x
|
| 12 |
Emad Shamsan, Maged Almezgagi, Mohammed Gamah, Naveed Khan, Abdulkareem Qasem, Liu Chuanchuan, Fan Haining. The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1389329
|
| 13 |
V. V. Tsukanov, A. A. Savchenko, M. A. Cherepnin, A. V. Vasyutin, E. V. Kasparov, V. D. Belenyuk, Ju. L. Tonkikh, A. G. Borisov. Subpopulation composition of blood T-helpers in hepatitis C patients with genotype 1 or 3. Meditsinskiy sovet = Medical Council 2024; (23): 168 doi: 10.21518/ms2023-447
|
| 14 |
Yuwei Xin, Feifei Liu, Diancheng Li, Jiaan Zhu. Viscoelasticity assessment for in vivo quantification of muscle contusion injury in rats using shear wave elastography. Ultrasound in Medicine & Biology 2022; 48(10): 2019 doi: 10.1016/j.ultrasmedbio.2022.05.026
|
| 15 |
Jin Lin Tan, Sandeep Sidhu-Brar, Richard Woodman, Mohamed Asif Chinnaratha. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Cancer 2023; 54(2): 325 doi: 10.1007/s12029-022-00842-y
|
| 16 |
Emmanuel Albuquerque‐Souza, Sinem E. Sahingur. Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis. Periodontology 2000 2022; 89(1): 125 doi: 10.1111/prd.12427
|
| 17 |
Afrodite Betsou, Maria Lambropoulou, Anastasia-Eirini Georgakopoulou, Nikolaos Kostomitsopoulos, Ourania Konstandi, Konstantinos Anagnostopoulos, Christos Tsalikidis, Constantinos E Simopoulos, Georgia Valsami, Alexandra K Tsaroucha. The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR. Journal of Pharmacy and Pharmacology 2021; 73(9): 1274 doi: 10.1093/jpp/rgab062
|
| 18 |
Chen Wang, Jinwen Liu, Yongmin Yan, Youwen Tan, Liu Jinhui. Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/1695802
|
| 19 |
J Alfredo Martínez, Marta Alonso-Bernáldez, Diego Martínez-Urbistondo, Juan A Vargas-Nuñez, Ana Ramírez de Molina, Alberto Dávalos, Omar Ramos-Lopez. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases. World Journal of Gastroenterology 2022; 28(44): 6230-6248 doi: 10.3748/wjg.v28.i44.6230
|
| 20 |
Liangyun Li, Yihui Bi, Shaoxi Diao, Xiaofeng Li, Tong Yuan, Tao Xu, Cheng Huang, Jun Li. Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice. Biochemical Pharmacology 2022; 200: 115032 doi: 10.1016/j.bcp.2022.115032
|
| 21 |
Vikram Nimbalkar, Neeraj Vyawahare. L-carnitine ameliorates bile duct ligation induced liver fibrosis via reducing the nitrosative stress in experimental animals: preclinical evidences. Heliyon 2021; 7(11): e08488 doi: 10.1016/j.heliyon.2021.e08488
|
| 22 |
Kun Wang, He-Qin Zhan, Ying Hu, Zhan-Yuan Yuan, Jun-Fa Yang, Da-Shuai Yang, Liang-Song Tao, Tao Xu. The role of interleukin-20 in liver disease: Functions, Mechanisms and Clinical applications. Heliyon 2024; : e29853 doi: 10.1016/j.heliyon.2024.e29853
|
| 23 |
Firathan SARIALTIN, Hasan YIGIT, Elif ERGUN, Pinar Nercis KOSAR. T1 relaxation time in the evaluation of liver fibrosis; with native MR relaxometry. Marmara Medical Journal 2023; 36(2): 197 doi: 10.5472/marumj.1302518
|
| 24 |
Marcelle de Carvalho Ribeiro, Gyongyi Szabo. Role of the Inflammasome in Liver Disease. Annual Review of Pathology: Mechanisms of Disease 2022; 17(1): 345 doi: 10.1146/annurev-pathmechdis-032521-102529
|
| 25 |
Mario M. Alba, Brandon Ebright, Brittney Hua, Ielyzaveta Slarve, Yiren Zhou, Yunyi Jia, Stan G. Louie, Bangyan L. Stiles. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1098467
|
| 26 |
Sherine Ahmed Elsherif, Ahmed Salah Alm. Role of macrophages in liver cirrhosis: fibrogenesis and resolution. Anatomy & Cell Biology 2022; 55(1): 14 doi: 10.5115/acb.21.046
|
| 27 |
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 2022; 86: 799 doi: 10.1016/j.semcancer.2022.01.005
|
| 28 |
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.781567
|
| 29 |
Long Huang, Qingsheng Yu, Hui Peng, Zhou Zhen. Network pharmacology and molecular docking technology for exploring the effect and mechanism of Radix Bupleuri and Radix Paeoniae Alba herb-pair on anti-hepatitis: A review. Medicine 2023; 102(48): e35443 doi: 10.1097/MD.0000000000035443
|
| 30 |
Hoda El Aggan, Sabah Mahmoud, Nevine El Deeb, Islam Eleishi, Assem El-Shendidi. Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-22022-5
|
| 31 |
Hafiz Abdul Khaliq, Mireille Alhouayek, Joëlle Quetin-Leclercq, Giulio G. Muccioli. 5’AMP-activated protein kinase: an emerging target of phytochemicals to treat chronic inflammatory diseases. Critical Reviews in Food Science and Nutrition 2022; : 1 doi: 10.1080/10408398.2022.2145264
|
| 32 |
Gong Feng, Luca Valenti, Vincent Wai-Sun Wong, Yasser Mahrous Fouad, Yusuf Yilmaz, Won Kim, Giada Sebastiani, Zobair M. Younossi, Virginia Hernandez-Gea, Ming-Hua Zheng. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2024; 21(1): 46 doi: 10.1038/s41575-023-00846-4
|
| 33 |
Vetriselvan Subramaniyan, Natasha Sura Anak Lubau, Nobendu Mukerjee, Vinoth Kumarasamy. Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential. Toxicology Reports 2023; 11: 355 doi: 10.1016/j.toxrep.2023.10.005
|
| 34 |
Erika Ramos-Tovar, Pablo Muriel. NLRP3 inflammasome in hepatic diseases: A pharmacological target. Biochemical Pharmacology 2023; 217: 115861 doi: 10.1016/j.bcp.2023.115861
|
| 35 |
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, Elizabeth Bernier, Calvin P. H. Vary, Meghan May, Karen L. Houseknecht. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. International Journal of Molecular Sciences 2020; 21(24): 9362 doi: 10.3390/ijms21249362
|
| 36 |
Pardis Habibi, Kimia Falamarzi, Niloofar Dehdari Ebrahimi, Mohammad Zarei, Mahdi Malekpour, Negar Azarpira. GDF11: An emerging therapeutic target for liver diseases and fibrosis. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18140
|
| 37 |
Thadiyan Parambil Ijinu, Kuttapetty Manikantan, Ajayakumar Lalitha Aneeshkumar, Vijayan Soorya, Panickamparambil Gopalakrishnan Latha, Varughese George, Palpu Pushpangadan. Ameliorative effect of the ethnomedicinal plant Blepharis maderaspatensis (L.) B.Heyne ex Roth on lipopolysaccharide-induced acute liver inflammation and oxidative stress in Wistar rat model. Phytomedicine Plus 2022; 2(2): 100247 doi: 10.1016/j.phyplu.2022.100247
|
| 38 |
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021; 81(4): 419 doi: 10.1007/s40265-020-01458-x
|
| 39 |
Yuan Fang, Lulu Zhou, Xiaoxuan Hu, Jingyun Guo, Jinmao Liao, Zheng Zhang. TLR4-MyD88-NF-κB signaling pathway contributes to the progression of secondary hepatic injury and fibrosis in hepatolithiasis. European Journal of Inflammation 2021; 19: 205873922110147 doi: 10.1177/20587392211014762
|
| 40 |
Anatoly I. Bozhkov, Rustam A. Akzhyhitov, Svitlana G. Bilovetska, Evgeny G. Ivanov, Nataliia I. Dobrianska, Anastasiia Yu Bondar. The Effect of Retinol Acetate on Liver Fibrosis Depends on the Temporal Features of the Development of Pathology. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101338 doi: 10.1016/j.jceh.2023.101338
|
| 41 |
Aaryani Tipirneni-Sajja, Sarah Brasher, Utsav Shrestha, Hayden Johnson, Cara Morin, Sanjaya K. Satapathy. Quantitative MRI of diffuse liver diseases: techniques and tissue-mimicking phantoms. Magnetic Resonance Materials in Physics, Biology and Medicine 2022; 36(4): 529 doi: 10.1007/s10334-022-01053-z
|
| 42 |
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk, Monika A. Jakubowska. When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis. The Journal of Physiology 2022; 600(11): 2579 doi: 10.1113/JP281135
|
| 43 |
Svitlana Bilovetska, Valentyn Kozheshkurt. ELECTRICAL CONDUCTIVITY OF LIVER TISSUE AS AN INDICATOR OF STRUCTURAL AND FUNCTIONAL ORGANIZATION OF LIVER TISSUE. Grail of Science 2023; (31): 151 doi: 10.36074/grail-of-science.15.09.2023.25
|
| 44 |
Bruno de Souza Basso, Matheus Scherer Bastos, Géssica Luana Antunes, Lucas Strassburger Matzenbacher, Kétlin Fernanda Rodrigues, Maria Claudia Rosa Garcia, Arieli Cruz de Sousa, Vitor Giancarlo Levorse, Carolina Luft, Giovana Vivan Tonial, Giovanna Mezzomo Pavanato, Leandro Vieira Astarita, Denizar Alberto da Silva Melo, Márcio Vinícius Fagundes Donadio, Eliane Romanato Santarém, Jarbas Rodrigues de Oliveira. Baccharis anomala DC. extract reduces inflammation and attenuates hepatic fibrosis in vivo by decreasing NF-kB and extracellular matrix compounds. Toxicon 2024; 237: 107560 doi: 10.1016/j.toxicon.2023.107560
|
| 45 |
Nejad Mohammadi, Fatemeh Nouri, Yazdan Asgari, Hemen Moradi-sardareh, Mahnaz Sharafi-Kolkeshvandi, Hossein Nemati, Gholam Ali Kardar. The immunostimulant effects of the rice ragged stunt virus genome on the growth and metastasis of breast cancer in mouse model. International Immunopharmacology 2023; 125: 111101 doi: 10.1016/j.intimp.2023.111101
|
| 46 |
Ying Jin, Qian Song, Rui He, Heng Diao, Huijie Gaoyang, Lei Wang, Lili Fan, Dapeng Wang. Nod-like receptor protein 3 inflammasome-mediated pyroptosis contributes to chronic NaAsO2 exposure-induced fibrotic changes and dysfunction in the liver of SD rats. Ecotoxicology and Environmental Safety 2024; 275: 116282 doi: 10.1016/j.ecoenv.2024.116282
|
| 47 |
Isabela A. Finamor, Caroline A. Bressan, Isabel Torres-Cuevas, Sergio Rius-Pérez, Marcelo da Veiga, Maria I. Rocha, Maria A. Pavanato, Salvador Pérez. Long-Term Aspartame Administration Leads to Fibrosis, Inflammasome Activation, and Gluconeogenesis Impairment in the Liver of Mice. Biology 2021; 10(2): 82 doi: 10.3390/biology10020082
|
| 48 |
Yue Xi, Peng-Fei Xu. Therapeutic potentials of fasudil in liver fibrosis. World Journal of Gastroenterology 2021; 27(45): 7859-7861 doi: 10.3748/wjg.v27.i45.7859
|
| 49 |
Waleed Ezzat Madboly, Magdi G. Shehata, Michael Sobhy M. Nashed, Ahmed M. Abu-Dief. Using power of calculated electrons to cut, analyze and exterminate the outer and the inner biological elements of hepatitis C virus without blood parameters disorders: In vitro study: low potential codified ions for hepatitis therapy. Asian Journal of Applied Science and Engineering 2022; 11(1): 45 doi: 10.18034/ajase.v11i1.16
|
| 50 |
Zhen Xu, Zhao Chen, Tongtong Lan, Yisa Han, Ning Yang, Chuhui Wang, Meng Tao, Hui Li, Yang Song, Xuezhen Ma, Muhammad Sajid Arshad. Protective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice. Journal of Food Biochemistry 2023; 2023: 1 doi: 10.1155/2023/6634450
|
| 51 |
Shuyang Cao, Jiancheng Miao, Miao Qian, Chen Zhu, Shiping Ding, Jun Yin, Liqi Zhu, Quan Zhang. Helicobacter hepaticus Infection Promotes the Progression of Liver Preneoplasia in BALB/c Mice via the Activation and Accumulation of High-Mobility Group Box-1. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.789752
|
| 52 |
|
| 53 |
Gherardo Baudo, Suhong Wu, Matteo Massaro, Haoran Liu, Hyunho Lee, Aijun Zhang, Dale J. Hamilton, Elvin Blanco. Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype. International Journal of Molecular Sciences 2023; 24(13): 10913 doi: 10.3390/ijms241310913
|
| 54 |
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang, Nariman Nezami. Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 2023; 15(9): 2624 doi: 10.3390/cancers15092624
|
| 55 |
Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang, Shusil K. Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I. Mohamed, Ahmed O. Kaseb, Michael Karin, Shabnam Shalapour. Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells. Proceedings of the National Academy of Sciences 2023; 120(19) doi: 10.1073/pnas.2300706120
|
| 56 |
Amara Lobo, Ying Liu, Yuqing Song, Song Liu, Rui Zhang, Hui Liang, Hui Xin. Effect of procyanidins on lipid metabolism and inflammation in rats exposed to alcohol and iron. Heliyon 2020; 6(9): e04847 doi: 10.1016/j.heliyon.2020.e04847
|
| 57 |
Ying Zhao, Yanni Zhou, Dan Wang, Ziwei Huang, Xiong Xiao, Qing Zheng, Shengfu Li, Dan Long, Li Feng. Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD). International Journal of Molecular Sciences 2023; 24(24): 17514 doi: 10.3390/ijms242417514
|
| 58 |
Ying Meng, Tong Zhao, Zhengyi Zhang, Dekui Zhang. The role of hepatic microenvironment in hepatic fibrosis development. Annals of Medicine 2022; 54(1): 2829 doi: 10.1080/07853890.2022.2132418
|
| 59 |
Tanvi Singla, Komal N Muneshwar, Aniket G Pathade, Seema Yelne. Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues. Cureus 2023; doi: 10.7759/cureus.45884
|
| 60 |
Aswathy R. Devan, Bhagyalakshmi Nair, Ayana R. Kumar, Lekshmi R. Nath. An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease. Biotechnology and Applied Biochemistry 2022; 69(2): 461 doi: 10.1002/bab.2123
|
| 61 |
Shengpeng Zhang, Peng Zhu, Jianan Yuan, Kunming Cheng, Qixiang Xu, Wei Chen, Zui Pan, Yongqiu Zheng. Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1149665
|
| 62 |
Subramanian Raghunandhakumar, Devaraj Ezhilarasan, Karthik Shree Harini. Thymoquinone protects thioacetamide‐induced chronic liver injury by inhibiting TGF‐β1/Smad3 axis in rats. Journal of Biochemical and Molecular Toxicology 2024; 38(4) doi: 10.1002/jbt.23694
|
| 63 |
Nahed Ismail, Aditya Sharma, Lynn Soong, David H. Walker. Protective Immunity and Immunopathology in Ehrlichiosis. Zoonoses 2022; 2(1) doi: 10.15212/ZOONOSES-2022-0009
|
| 64 |
Xudong Song, Jiayi Shi, Jieting Liu, Yong Liu, Yang Yu, Yufei Qiu, Zhiqin Cao, Yu Pan, Xiaohuan Yuan, Yanhui Chu, Dan Wu. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway. Molecular Medicine 2022; 28(1) doi: 10.1186/s10020-022-00508-2
|
| 65 |
Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice. Biomaterials Advances 2023; 154: 213627 doi: 10.1016/j.bioadv.2023.213627
|
| 66 |
Yang Zhang, Yuan Wu, Wenjuan Shen, Bingyu Wang, Xingxing Yuan. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review). Molecular Medicine Reports 2022; 25(6) doi: 10.3892/mmr.2022.12724
|
| 67 |
Xingyao Hu, Guangbin Shang, Jie Zhang, Zhong Chen, Liu Fu, Jun Li, Xiaonan Lu. Clinical Yi-guan decoction for liver cirrhosis. Medicine 2021; 100(13): e24530 doi: 10.1097/MD.0000000000024530
|
| 68 |
Devaraj Ezhilarasan, Karthik Shree Harini, Munusamy Karthick, Prathap Lavanya. Boldine protects against carbon tetrachloride‐induced chronic liver injury by regulating NF‐κB signaling pathway. Journal of Biochemical and Molecular Toxicology 2024; 38(4) doi: 10.1002/jbt.23691
|
| 69 |
Andrea PASTA, Stefano KAYALI, Paolo BORRO. The study of hepatic fibrosis: state of art and future perspectives. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2022; 180(12) doi: 10.23736/S0393-3660.21.04711-2
|
| 70 |
Xiaohe Li, Hailong Li, Shanshan Zhang, Ruotong Zhang, Jinhe Li, Yiying Wei, Cheng Yang, Fubo Zhang, Honggang Zhou. Protective effect of Idelalisib on carbon tetrachloride‐induced liver fibrosis via microRNA‐124‐3P/phosphatidylinositol‐3‐hydroxykinase signalling pathway. Journal of Cellular and Molecular Medicine 2021; 25(24): 11185 doi: 10.1111/jcmm.17039
|
| 71 |
Feng Gong, Kenneth I. Zheng, Liang-Jie Tang, Gang Li, Rafael S. Rios, Ou-Yang Huang, Yang-Yang Li, Christopher D. Byrne, Giovanni Targher, Man Mi, Na He, Hong-Lei Ma, Ming-Hua Zheng. Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?. iLIVER 2022; 1(1): 30 doi: 10.1016/j.iliver.2022.02.001
|
| 72 |
Xiao-Li He, Yong-Hong Hu, Jia-Mei Chen, Ding-Qi Zhang, Hai-Lin Yang, Lin-Zhang Zhang, Yong-Ping Mu, Hua Zhang, Gao-Feng Chen, Wei Liu, Ping Liu. SNS-032 attenuates liver fibrosis by anti-active hepatic stellate cells via inhibition of cyclin dependent kinase 9. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1016552
|
| 73 |
Yan Ning, Xinyue Dou, Zhichao Wang, Kao Shi, Zeping Wang, Chuan Ding, Xianan Sang, Xiang Zhong, Meiyu Shao, Xin Han, Gang Cao. SIRT3: A potential therapeutic target for liver fibrosis. Pharmacology & Therapeutics 2024; 257: 108639 doi: 10.1016/j.pharmthera.2024.108639
|
| 74 |
Ahlam M. Alhusaini, Rahaf Alsoghayer, Lina Alhushan, Abeer M. Alanazi, Iman H. Hasan. Acetyl-L-Carnitine and Liposomal Co-Enzyme Q10 Attenuate Hepatic Inflammation, Apoptosis, and Fibrosis Induced by Propionic Acid. International Journal of Molecular Sciences 2023; 24(14): 11519 doi: 10.3390/ijms241411519
|
| 75 |
Min Li, Jigang Zhang, Jingmeng Fang, Yuan Xin, Hao Zhu, Xueying Ding. Pre-administration of human umbilical cord mesenchymal stem cells has better therapeutic efficacy in rats with D-galactosamine-induced acute liver failure. International Immunopharmacology 2024; 130: 111672 doi: 10.1016/j.intimp.2024.111672
|
| 76 |
Haiying Liu, Linyu Dai, Ming Wang, Fumin Feng, Yonghong Xiao. Tunicamycin Induces Hepatic Stellate Cell Apoptosis Through Calpain-2/Ca2 +-Dependent Endoplasmic Reticulum Stress Pathway. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.684857
|
| 77 |
Su-Wen Jiang, Xiang Lian, Ai-Rong Hu, Jia-Lin Lu, Zhe-Yun He, Xiao-Jun Shi, De-Dong Zhu, Zong-Yi Wang, Guan-Cheng Huang. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication. World Journal of Gastroenterology 2023; 29(16): 2479-2494 doi: 10.3748/wjg.v29.i16.2479
|
| 78 |
Qi Wang, Lu Ma, Baofei Sun, Aihua Zhang. Reduced Peripheral Blood Mitochondrial DNA Copy Number as Identification Biomarker of Suspected Arsenic-Induced Liver Damage. Biological Trace Element Research 2023; 201(11): 5083 doi: 10.1007/s12011-023-03584-5
|
| 79 |
Ling Li, Yanting Ji, Lili Zhang, Hengji Cai, Zhoujing Ji, Lixiong Gu, Shengju Yang. Wogonin inhibits the growth of HT144 melanoma via regulating hedgehog signaling-mediated inflammation and glycolysis. International Immunopharmacology 2021; 101: 108222 doi: 10.1016/j.intimp.2021.108222
|
| 80 |
Jennifer C. Ku, Jacob Raiten, Yong Li. Understanding fibrosis: Mechanisms, clinical implications, current therapies, and prospects for future interventions. Biomedical Engineering Advances 2024; 7: 100118 doi: 10.1016/j.bea.2024.100118
|
| 81 |
Elena Magnani, Filippo Macchi, Bhavani P. Madakashira, Chi Zhang, Fatima Alaydaroos, Kirsten C. Sadler. uhrf1 and dnmt1 Loss Induces an Immune Response in Zebrafish Livers Due to Viral Mimicry by Transposable Elements. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.627926
|
| 82 |
Arbinda Pokharel, Sudhamshu KC, Pukar Thapa, Niyanta Karki, Rupesh Shrestha, Bikash Jaishi, Mukesh S Paudel. The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease. Cureus 2021; doi: 10.7759/cureus.16687
|
| 83 |
Liu-Hong Shen, Lei Fan, Yue Zhang, Ying-Kun Zhu, Xiao-Lan Zong, Guang-Neng Peng, Sui-Zhong Cao. Protective Effect and Mechanism of Placenta Extract on Liver. Nutrients 2022; 14(23): 5071 doi: 10.3390/nu14235071
|
| 84 |
Chen-Yu Zhang, Xiao-Hua Tan, Hui-Hui Yang, Ling Jin, Jie-Ru Hong, Yong Zhou, Xiao-Ting Huang. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR. International Journal of Molecular Sciences 2022; 23(15): 8267 doi: 10.3390/ijms23158267
|
| 85 |
Noman Ullah Wazir, Tania Khattak, Usama Khan, Saman Hussain, Syed Mohammad Tahir Shah, Muhammad Haris, Sobia Haris, Farah Deeba. Unveiling the Therapeutic Potential of Vitamin-E in Preventing Inflammation and Stromal Congestion in Alcoholic Liver Injury. Cureus 2024; doi: 10.7759/cureus.54931
|
| 86 |
Bingmin Wu, Lan Huang, Yange Wang, Lishan Zeng, Ying Lin, Jingyan Li, Shaogui Wang, Guifang Zhang, Lin An. Yao medicine Amydrium hainanense suppresses hepatic fibrosis by repressing hepatic stellate cell activation via STAT3 signaling. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1043022
|
| 87 |
Hao Xu, Li Zhang, Duowen Xu, Weibo Deng, Wenbao Yang, Futian Tang, Mingxu Da. Knockout of calpain‐1 protects against high‐fat diet‐induced liver dysfunction in mouse through inhibiting oxidative stress and inflammation. Food Science & Nutrition 2021; 9(1): 367 doi: 10.1002/fsn3.2002
|
| 88 |
Xiuru Gong, Tingting Zhu, Xiaolin Peng, Dongwei Xing, Minguang Zhang. Diagnostic Accuracy of Transient Elastography and Two-Dimensional
Shear Wave Elastography for Staging Liver Fibrosis in Children or
Adolescents: A Systematic Review and Meta-Analysis. Current Medical Imaging Formerly Current Medical Imaging Reviews 2023; 19(11) doi: 10.2174/1573405618666220829152956
|
| 89 |
Mei Yang, Menghui Wang, Nanfang Li. Advances in pathogenesis of preeclampsia. Archives of Gynecology and Obstetrics 2024; 309(5): 1815 doi: 10.1007/s00404-024-07393-6
|
| 90 |
Shuo Zheng, Yihong Huang. Unveiling the Anti-cancer Efficiency of Chebulagic Acid-Mediated Apoptotic Mechanisms in HepG2 Cell Line. International Journal of Pharmacology 2021; 17(4): 229 doi: 10.3923/ijp.2021.229.242
|
| 91 |
Hafiza Madiha Jaffar, Fahad Al‐Asmari, Faima Atta Khan, Muhammad Abdul Rahim, Eliasse Zongo. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review. Food Science & Nutrition 2024; doi: 10.1002/fsn3.4010
|
| 92 |
Yuan Yao, Yunfeng Shen. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0699
|
| 93 |
Н.А. Онищенко, А.О. Никольская, М.Ю. Шагидулин. Progressive dysfunction of the immune system as a factor preventing recoverable regeneration of the liver in chronic fibrosing diseases. Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» 2023; 67(3): 109 doi: 10.25557/0031-2991.2023.03.109-123
|
| 94 |
Chan Mo, Shuwen Xie, Bin Liu, Weichao Zhong, Ting Zeng, Sha Huang, Yuqi Lai, Guanghui Deng, Chuying Zhou, Weixin Yan, Yuyao Chen, Shaohui Huang, Lei Gao, Zhiping Lv. Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death & Disease 2021; 12(1) doi: 10.1038/s41419-020-03277-0
|
| 95 |
Hanaa A El-Araby, Magdy A Saber, Noha M Radwan, Doha M Taie, Nermin M Adawy, Ahmad M Sira. Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progression. Annals of Hepatology 2021; 21: 100263 doi: 10.1016/j.aohep.2020.09.007
|
| 96 |
Khaled Alkhuder. Raman scattering-based optical sensing of chronic liver diseases. Photodiagnosis and Photodynamic Therapy 2023; 42: 103505 doi: 10.1016/j.pdpdt.2023.103505
|
| 97 |
Rong Xie, Shaodong Chen, Fang Li, Liu Yang, Bangliang Yu. Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(2) doi: 10.1002/jbt.23251
|
| 98 |
Samuel Martínez-Meza, Bhavya Singh, Douglas F. Nixon, Nicholas Dopkins, Louie Mar A. Gangcuangco. The brain-liver cholinergic anti-inflammatory pathway and viral infections. Bioelectronic Medicine 2023; 9(1) doi: 10.1186/s42234-023-00132-3
|
| 99 |
Jyoti Chhimwal, Abhishek Goel, Mahesh Sukapaka, Vikram Patial, Yogendra Padwad. Phloretin mitigates oxidative injury, inflammation, and fibrogenic responses via restoration of autophagic flux in in vitro and preclinical models of NAFLD. The Journal of Nutritional Biochemistry 2022; 107: 109062 doi: 10.1016/j.jnutbio.2022.109062
|
| 100 |
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
|
| 101 |
Abdelrahim Alqudah, Rawan AbuDalo, Esam Qnais, Mohammed Wedyan, Muna Oqal, Lana McClements. The emerging importance of immunophilins in fibrosis development. Molecular and Cellular Biochemistry 2023; 478(6): 1281 doi: 10.1007/s11010-022-04591-1
|
| 102 |
Maria Lina Tornesello, Anna Lucia Tornesello, Noemy Starita, Andrea Cerasuolo, Francesco Izzo, Luigi Buonaguro, Franco Maria Buonaguro. Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data. Expert Opinion on Therapeutic Targets 2022; 26(9): 767 doi: 10.1080/14728222.2022.2147062
|
| 103 |
Aliaa M. Radwan, Shahenda A. Fatoh, Ahmed Massoud, Ehab Tousson. Effectiveness of curcumin nanoparticles in rat liver fibrosis caused by thioacetamide. Environmental Toxicology 2024; 39(1): 388 doi: 10.1002/tox.23984
|
| 104 |
Xiaolin Xiao, Qichao Hu, Xinyu Deng, Kaiyun Shi, Wenwen Zhang, Yinxiao Jiang, Xiao Ma, Jinhao Zeng, Xiaoyin Wang. Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. Pharmacological Research 2022; 175: 106005 doi: 10.1016/j.phrs.2021.106005
|
| 105 |
Chao Hou, Dong Wang, Mingxia Zhao, Petek Ballar, Xinru Zhang, Qiong Mei, Wei Wang, Xiang Li, Qiang Sheng, Jun Liu, Chuansheng Wei, Yujun Shen, Yi Yang, Peng Wang, Juntang Shao, Sa Xu, Fuyan Wang, Yang Sun, Yuxian Shen. MANF brakes TLR4 signaling by competitively binding S100A8 with S100A9 to regulate macrophage phenotypes in hepatic fibrosis. Acta Pharmaceutica Sinica B 2023; 13(10): 4234 doi: 10.1016/j.apsb.2023.07.027
|
| 106 |
Lei Tang, Jun Shi, Manshu Yu, Yun Shan, Juan Zhao, Meixiao Sheng. Isolation and characterization of peritoneal microvascular pericytes. FEBS Open Bio 2022; 12(4): 784 doi: 10.1002/2211-5463.13386
|
| 107 |
Paulina Vidal-Cevallos, Adriana P. Sorroza-Martínez, Norberto C. Chávez-Tapia, Misael Uribe, Eduardo E. Montalvo-Javé, Natalia Nuño-Lámbarri. The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum. International Journal of Molecular Sciences 2024; 25(8): 4397 doi: 10.3390/ijms25084397
|